GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » Current Deferred Revenue

BB Biotech AG (XSWX:BION) Current Deferred Revenue


View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG Current Deferred Revenue?

Current Deferred Revenue does not apply to banks.


BB Biotech AG Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (XSWX:BION) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Executives
Prof. Dr. Mads Krogsgaard Thomsen Supervisory Board